Abstract:Background The prescription of injectable anticipatory medications ahead of possible need for last-days-of-life symptom relief is established community practice internationally. Healthcare teams and policy makers view anticipatory medication as having a key role in optimising effective and timely symptom control. However, how these medications are subsequently administered (used) is unclear and warrants detailed investigation to inform interdisciplinary practice and guidance. Objective To identify the frequency, timing and recorded circumstances of the administration of injectable end-of-life anticipatory medications prescribed for patients living at home and in residential care. Design A retrospective mixed-methods observational study using general practitioner (family doctor) and community nursing held clinical records. Setting(s) Community-based care in two English counties. Participants 167 deceased adult patients (aged 18+) registered with eleven general practitioner practices and two associated community nursing services. These were patients prescribed anticipatory medications, identified from the 30 most recent deaths per practice. Patients died between 1 March 2017 and 25 September 2019, from any cause except trauma, sudden death or suicide. Methods Patient characteristics, anticipatory medications discussions, recorded administration contexts and decision-making, medication details, recorded symptom control and comfort at death were collected from clinical records. Data analysis combined quantitative and qualitative analyses in a mixed methods approach. Results Anticipatory medications were administered to 59 % (100/167) patients, commenced between 0 and 586 days before death (median 3 days). Their usage was similar for patients who died from cancer and non-cancer conditions. Anticipatory medications were almost universally started and titrated by visiting nurses. Eleven patients had medications started between 59 days and 586 days before death for recorded reversible non-end-of-life care conditions. Only 5 % (5/100) of patient records contained detailed accounts of patient participation in decisions to start medications: four were recorded as being reluctant to commence medications but agreed to trial injections to relieve symptoms. Crucially, there was recurrent under-recording of the effectiveness of injectable medications and patient comfort. Conclusions Prescribed medications were commonly administered by visiting community nurses to help manage last-days-of-life symptoms. However, patient records infrequently referred to the effectiveness of administered medication and perceived patient comfort. Most recorded references to the patient and family preferences for involvement in anticipatory medication decision-making and their experiences of care are brief and perfunctory. More detailed information should be routinely recorded in clinical records to enable assessment of appropriate and effective use of anticipatory medicines and how inter-professional collaboration and services could be developed to provide adequate twenty-four-hour cover. Tweetable abstract Effectiveness of injectable end-of-life symptom control medications and patient comfort often under-recorded @Ben_Bowers__ @PELi_Cam @TheQNI.

Anticipatory prescribing of injectable controlled drugs (ICDs) in care homes: a qualitative observational study of staff role, uncertain dying and hospital transfer at the end-of-life

Administering injectable medications prescribed in the anticipation of the end of life in the community: A mixed-methods observational study

GPs' decisions about prescribing end-of-life anticipatory medications: a qualitative study

What happens when pharmacist independent prescribers lead on medicine management in older people's care homes: a qualitative study

The integrated implementation of two end-of-life care tools in nursing care homes in the UK: an in-depth evaluation

Implementing a quality improvement programme in palliative care in care homes: a qualitative study

Doctors’ and nurses’ views and experience of transferring patients from critical care home to die: A qualitative exploratory study

Impact of home healthcare on end-of-life outcomes for people with dementia: a systematic review

Prevalence of Value-Based Care for Older People with Dementia Likely to Be Nearing End of Life: A Hospital Retrospective Cohort

Advanced care planning in care homes for older people: a qualitative study of the views of care staff and families

A single-center retrospective analysis of interventions provided to geriatric inpatients receiving end-of-life care

The ‘work’ of managing medications when someone is seriously ill and dying at home: A longitudinal qualitative case study of patient and family perspectives’

Supported: Supporting, enabling, and sustaining homecare workers to deliver end-of-life care: A qualitative study protocol

Paramedics' experiences of end-of-life care decision making with regard to nursing home residents: an exploration of influential issues and factors

The influence of care home registration type and size on senior care leader's confidence to provide palliative and end-of-life care: an explanatory sequential mixed methods study

The Bromhead Care Home Service: the impact of a service for care home residents with dementia on hospital admission and dying in preferred place of care

Post‐discharge medicines management: the experiences, perceptions and roles of older people and their family carers

Increasing the chance of dying at home: roles, tasks and approaches of general practitioners enabling palliative care: a systematic review of qualitative literature

Multidisciplinary residential home intervention to improve outcomes for frail residents

Understanding the factors associated with patients with dementia achieving their preferred place of death: a retrospective cohort study

'I don't think they really link together, do they?' An ethnography of multi-professional involvement in advance care planning in nursing homes